Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track route
Feb 17 (Reuters) – Disc Medicine said on Tuesday it will pursue a traditional U.S. approval pathway for…
NRx submits 70,000-patient ketamine data to US FDA
NRx Pharmaceuticals (나스닥: NRXP)는 70,000명 이상의 환자가 정맥 투여 케타민 또는 비강 S-케타민으로 치료받은 실제 세계…